1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends

Aptamers Market Analysis By Types (Nucleic Acid & Peptide), By Application (Diagnostics, Therapeutics, Research & Developments, Others), By Region, And Segment Forecasts, 2014 - 2025

  • June 2017
  • 75 pages
  • Grand View Research
Report ID: 4998555

Summary

Table of Contents

The global aptamers market is expected to reach USD 8.91 billion by 2025 according to a new report by Grand View Research, Inc.

Advancements in aptamer development technologies, increasing R&D, and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market.

Numerous advantages offered by these small molecules in comparison to established antibodies have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth. Integrated DNA Technologies, Inc. introduced a next-generation product, Ultramers that contain aptamer template length up to 200 bases. According to the company, this new product will be apt for biotechnology applications such as gene and clone construction. Thus, new developments in this field are expected to boost usage of these products in different application areas, thereby driving market growth.

Furthermore, growing incidence of life-threatening diseases such as cancer has directed many companies to introduce new & effective detection assays based on aptamer therapy. In March 2017, Aptamer Sciences, Inc. unveiled multiprotein biomarker assay by using this technology for the detection of lung cancer. This kit is designed for early detection and diagnosis of non-small cell lung cancer by identifying a suitable biomarker. Such types of new product launches are expected to trigger the acceptance of these therapies, leading to market growth to a great extent. In addition, increasing number of small-scale startups, government organizations, rising number of products under clinical investigation, and growing number of academic research laboratories investigating the potential of aptamers are anticipated to support future growth of this market.

In contrast, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate the clinical investigation during late-stage clinical studies. This factor is likely to affect growth of this market negatively. In addition, other factors such as low awareness about these technologies in middle- & low-income countries and inadequate regulatory structure may hamper the overall growth.

Further Key Findings from the Report Suggest:
• The nucleic acid aptamer segment held majority of the revenue share in 2016 due to rise in demand for nucleic acid-based diagnostic kits and therapeutics across the globe
• Diagnostics application dominated the application segment in 2016 due to introduction of novel diagnostic kits by key players
• Developed regions such as North America and Europe dominated the global market due to growing demand for aptamer therapeutics coupled with rise in number of research laboratories
• Some of the key players include Aptamer Group; Aptamer Sciences, Inc.; Aptagen, LLC; Base Pair Biotechnologies, Inc.; Ophthotech Corporation; and others

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Oncology Biosimilars Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

  • $ 5795
  • Industry report
  • September 2017
  • by Transparency Market Research

Global Oncology Biosimilars Market: Overview This report on the oncology biosimilars market analyzes the current and future scenario of the global market. Increasing prevalence of cancer, innovation in ...

Bioprocess Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

  • $ 5795
  • Industry report
  • September 2017
  • by Transparency Market Research

Global Bioprocess Technology Market: Overview The global market of bioprocess technology is predicted to witness an impressive growth during the forecast period, 2017 – 2022. The bioprocess technology ...

Biopharmaceutical Contract Manufacturing Market: Oncology Segment by Therapeutic Area to Dominate the Global Market Through 2027: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027

  • $ 5000
  • Industry report
  • September 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

Future Market Insights presents a detailed forecast of the global biopharmaceutical contract manufacturing market in a new report titled “Biopharmaceutical Contract Manufacturing Market: Global Industry ...

Global Biosimilars Market

July 2017 $ 4250

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.